We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AQST market cap is 316.66M. The company's latest EPS is USD -0.7423 and P/E is -5.70.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 11.46M | 10.68M | 11.13M | 13.24M | 13M |
Operating Income | -8.85M | -10.71M | -4.61M | -4.21M | -2.38M |
Net Income | -12.54M | -12.35M | 8.07M | -5.79M | -2.04M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 67.43M | 52.61M | 45.85M | 50.83M | 47.68M |
Operating Income | -48.93M | -52.67M | -42.89M | -34.68M | -42.07M |
Net Income | -61.38M | -66.25M | -55.78M | -70.54M | -54.41M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 51.85M | 57.07M | 61.29M | 56.99M | 59.45M |
Total Liabilities | 159.66M | 175.62M | 170.52M | 163.65M | 162.38M |
Total Equity | -107.82M | -118.55M | -109.24M | -106.65M | -102.93M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 86.85M | 78.48M | 62.88M | 61.99M | 57.07M |
Total Liabilities | 76.77M | 84.6M | 111.38M | 144.13M | 175.62M |
Total Equity | 10.08M | -6.12M | -48.5M | -82.13M | -118.55M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -18.24M | -9.79M | 8.82M | 909k | -1.44M |
Investing | -2.5M | -2.52M | -2k | -828k | -979k |
Financing | 11.36M | 11.56M | -9.21M | -17.46M | 61k |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.99M | -60.21M | -45.46M | -32.98M | -9.79M |
Investing | -1.82M | -663k | -517k | -913k | -2.52M |
Financing | 58.04M | 49.6M | 28.46M | 30.11M | 11.56M |
Market Cap | 316.66M |
Price to Earnings Ratio | -5.70 |
Price to Sales Ratio | 6.5 |
Price to Cash Ratio | 11.37 |
Price to Book Ratio | -2.62 |
Dividend Yield | - |
Shares Outstanding | 73.3M |
Average Volume (1 week) | 2.63M |
Average Volume (1 Month) | 3.88M |
52 Week Change | 408.24% |
52 Week High | 6.23 |
52 Week Low | 0.821601 |
Spread (Intraday) | 0.14 (3.15%) |
Company Name | Aquestive Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.aquestive.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions